Home Applications 214008 Application 214008
Type ANDA
Sponsor NATCO Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE TIPIRACIL HYDROCHLORIDE; TRIFLURIDINE TABLET;ORAL EQ 6.14MG BASE;15MG No No 002 TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE TIPIRACIL HYDROCHLORIDE; TRIFLURIDINE TABLET;ORAL EQ 8.19MG BASE;20MG No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A214008-001 TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE TIPIRACIL HYDROCHLORIDE; TRIFLURIDINE EQ 6.14MG BASE;15MG TABLET / ORAL AB 2023-06-13 A214008-002 TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE TIPIRACIL HYDROCHLORIDE; TRIFLURIDINE EQ 8.19MG BASE;20MG TABLET / ORAL AB 2023-06-13
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 2 of 2 · 50 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2023-12-20 04:57 UTC 2023-12 A214008-001 TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE EQ 6.14MG BASE;15MG TABLET / ORAL AB 2023-06-13 ea1830bbd6c7…2023-12-20 04:57 UTC 2023-12 A214008-002 TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE EQ 8.19MG BASE;20MG TABLET / ORAL AB 2023-06-13 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A214008-001 TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE EQ 6.14MG BASE;15MG TABLET / ORAL AB 2023-06-13 a72a2bbeb626…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A214008-002 TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE EQ 8.19MG BASE;20MG TABLET / ORAL AB 2023-06-13 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A214008-001 TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE EQ 6.14MG BASE;15MG TABLET / ORAL AB 2023-06-13 9b2671bbb829…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A214008-002 TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE EQ 8.19MG BASE;20MG TABLET / ORAL AB 2023-06-13 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A214008-001 TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE EQ 6.14MG BASE;15MG TABLET / ORAL AB 2023-06-13 a67488948f0b…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A214008-002 TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE EQ 8.19MG BASE;20MG TABLET / ORAL AB 2023-06-13 a67488948f0b…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A214008-001 TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE EQ 6.14MG BASE;15MG TABLET / ORAL AB 2023-06-13 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A214008-002 TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE EQ 8.19MG BASE;20MG TABLET / ORAL AB 2023-06-13 a50c72e98297…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 50 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents# Document, Submission type, Date table Document Submission type Date 74735 ORIG 2023-07-13